“…Second, consistent with a role for OX in impulsivity-like behaviors, the OXr1 antagonist SB-334867 peripherally administered regulated impulsive behavior under both baseline and cocaine-stimulated conditions in a dynorphin-sensitive manner in food-restricted rats, as measured by premature responses exhibited in the 5-choice serial reaction time task (5-CSRTT) (Muschamp et al, 2014). Third, recent studies have highlighted the role of OX system in binge-like consumption of rewarding stimulus (sucrose, saccharin and ethanol) in non-dependent animals (Alcaraz-Iborra et al, 2014;Anderson et al, 2014;Olney et al, 2015) as measured by the Drinking in the Dark (DID) paradigm, a wellestablished procedure to reproduce pre-dependent episodes of human binge consumption patterns in mice (Thiele and Navarro, 2014). Thus, the OXr1 antagonist SB-334867 reduced sucrose, saccharin (AlcarazIborra et al, 2014) and ethanol (Anderson et al, 2014;Olney et al, 2015) binge-like drinking when administered peripherally and ethanol binge-like drinking when centrally infused (Carvajal et al, 2015) in non-deprived mice.…”